MBBS in China for Indians: the post-pandemic uncertainty

MBBS in China was for years the largest single foreign destination for Indian medical students by enrollment. The pandemic era 2020-2022 disrupted Chinese medical education for Indian students substantially, with extended campus closures, online-only instruction that does not satisfy NMC clinical exposure requirements, and visa difficulties that left thousands of students stranded mid-degree. Campuses have since reopened, but the structural weaknesses declining FMGE outcomes, tightened NMC requirements including the Chinese medical license requirement, and ongoing geopolitical uncertainty have changed the realistic value proposition. This is the editorial reference on what the China MBBS pathway actually delivers in 2026.

---

China’s medical education sector has historically attracted substantial Indian student enrollment at peak years before the pandemic, more than 20,000 Indian students were enrolled across approximately 45 NMC-approved Chinese medical universities. The attraction was structural: relatively low tuition (₹3-6 lakh per year), modern infrastructure at top institutions, large affiliated hospital networks, English-medium programs, and established admission processes that handled high foreign student volumes. The combination produced one of the largest foreign MBBS pathways for Indian families seeking alternatives to expensive private medical colleges in India.

The pandemic era disrupted the pathway substantially. From early 2020 through most of 2022, Chinese campuses operated under strict pandemic restrictions including extended campus closures, online-only instruction, and severely limited visa issuance for international students. Indian students enrolled before the pandemic spent two or more years in online-only classes from India a period that the National Medical Commission has explicitly stated does not satisfy the clinical exposure requirements for FMGE/NExT eligibility. The cohorts most affected face continuing complications even after their return to China and degree completion.

The post-pandemic reality is more complex than the China MBBS marketing materials present. Campus operations have substantially normalised. Visas are being issued for new students. New cohorts can have rigorous on-campus, English-medium experiences with proper clinical training. But the FMGE outcomes have weakened the FMGE 2024 pass rate for Indian students completing MBBS in China was 19.45% (2,765 of 14,214 students), substantially below the country averages of stronger destinations. Additional NMC requirements including a valid Chinese medical license requirement add further pathway complexity that students from other foreign destinations do not face.

This piece covers the realistic China MBBS pathway in 2026 what changed during the pandemic era, what the current operational reality is, and how Indian families should evaluate the pathway given the structural and outcome weaknesses.

What changed during the pandemic era

The pandemic era January 2020 through approximately late 2022 produced specific disruptions that Indian families considering China MBBS should understand because the consequences continue to affect the post-pandemic landscape:

Campus closures and online instruction. Chinese universities closed campuses to international students from early 2020 onward. International student visas (Type X1) were largely suspended. Indian students enrolled in Chinese medical programs were either stranded outside China unable to return, or were students who had not yet traveled and had to begin programs entirely online from India.

Online instruction did not include clinical exposure. Multiple semesters of online instruction during the pandemic period covered theoretical content but did not provide hospital-based clinical training. Bedside teaching, patient examination, surgical observation, and integrated clinical exposure cannot be conducted online. The clinical component gaps for pandemic-era cohorts are substantial.

NMC position on online MBBS. The National Medical Commission has been explicit that MBBS programs completed entirely or substantially online do not satisfy the requirements for FMGE/NExT eligibility under FMGL 2021. The position applies to online instruction periods regardless of whether the disruption was caused by pandemic, war, or other factors. Indian students whose Chinese MBBS includes substantial online-only periods may face eligibility complications at FMGE registration.

Visa difficulties. Even after some normalisation, visa issuance for Indian students returning to or beginning Chinese medical programs faced delays and complications throughout 2022 and into 2023. Some students with valid admissions and paid fees were unable to obtain timely visas, creating extended program disruptions.

Mid-degree disruption cohorts. Students who began Chinese MBBS in 2018-2019, completed approximately 1-2 years on campus, then spent 2-3 years online during the pandemic, and finally returned to China for clinical years face complex eligibility determinations. Each individual case may require specific NMC review.

Pre-pandemic cohorts. Indian students who completed Chinese MBBS in 2019 or earlier are governed by the prior FMGE eligibility framework with their pathway largely unaffected by pandemic-era disruptions. The transitional cohorts are the specific concern.

What the current operational reality looks like

For Indian students considering Chinese MBBS in 2026, the operational reality is substantially normalised relative to peak pandemic disruption:

Campus operations normal. Chinese universities have resumed normal on-campus teaching for international students. Bedside clinical training, hospital rotations, and laboratory instruction are occurring at typical pre-pandemic standards at major institutions.

Visa issuance normalised. Type X1 student visas are being issued for Indian students with valid admissions to recognised institutions. Processing times are typical. Indian students traveling to China for medical education face visa procedures comparable to pre-pandemic norms.

English-medium programs available. English-medium MBBS programs at NMC-recognised institutions continue. The implementation quality varies across institutions; top institutions provide rigorous English-medium throughout, while some smaller institutions have variable English implementation in clinical years.

Cost structure unchanged. Annual tuition at NMC-approved Chinese medical universities continues at approximately ₹3-6 lakh per year for international students. Total six-year cost typically ₹18-35 lakh including hostel, food, and miscellaneous expenses. The cost structure is competitive with most foreign MBBS alternatives.

Indian student community. Approximately 9,000-12,000 Indian students remain enrolled across Chinese medical universities a substantial reduction from peak pre-pandemic levels but still a major Indian foreign-student concentration.

The NMC rules specific to Chinese MBBS

NMC has implemented several requirements that apply specifically or with particular emphasis to Chinese MBBS graduates:

The 45-48 NMC-approved institutions. NMC last published a comprehensive list of approved Chinese medical institutions in 2019, identifying approximately 45 institutions whose programs satisfy the recognition requirements. Subsequent guidance has indicated that approximately 45-48 Chinese institutions remain recognised. Indian students must enroll at one of these specific institutions; Chinese medical universities not on the recognised list do not produce FMGE-eligible degrees.

The Chinese medical license requirement. Recent NMC guidance has reiterated that Indian students completing Chinese MBBS must hold a valid Chinese medical license confirming completion of clinical training in actual hospital settings rather than online before becoming eligible to sit FMGE. The Chinese medical license is obtained through the Chinese national medical qualification examination (Yiminsheng), which Indian students must pass. The license requirement substantially raises the testing burden Indian students must pass both the Chinese qualifying examination and the Indian FMGE.

The HSK-4 Chinese language requirement at some institutions. Several Chinese medical universities require Indian students to achieve HSK-4 (Hanyu Shuiping Kaoshi level 4) Chinese language proficiency before final-year clinical rotations. The requirement reflects the practical reality that Chinese hospital patients communicate primarily in Mandarin, and meaningful clinical exposure requires basic Chinese proficiency. The language requirement adds preparation burden during the program.

The bilingual program restriction. Some Chinese institutions historically offered bilingual MBBS programs combining Chinese and English instruction. NMC has been clear that these programs may not satisfy the English-medium requirement under FMGL 2021. Indian students should enroll specifically in fully English-medium programs at recognised institutions and verify the program designation in the I-20 equivalent admission documentation.

Internship at the same institution requirement. The 12-month internship under FMGL 2021 must be completed at the same Chinese medical university as the academic degree. Internships at affiliated hospitals operated by the same university typically satisfy this; internships at unaffiliated hospitals do not. Verification matters for institutions where hospital affiliations have changed.

The FMGE outcomes from Chinese MBBS

FMGE outcomes from Chinese medical universities have weakened in recent years:

Country-level FMGE 2024 pass rate: 19.45%. Of 14,214 Indian students from Chinese medical universities who appeared for FMGE 2024, approximately 2,765 cleared the test a country pass rate of approximately 19.45%. This is materially below stronger alternatives (Bangladesh 26.79%, Russia 29.54%, Georgia 35.65%) and substantially below top-tier alternatives.

Institution-level variation. Within China, institution-level pass rates vary substantially. Top institutions with strong academic reputations and established Indian student preparation infrastructure (some institutions in Tianjin, Wuhan, Beijing, Nanjing) produce pass rates of 25-35%. Lower-tier institutions, particularly those with weak English-medium implementation or limited clinical exposure, produce pass rates below 10%. The institutional selection within China is consequential.

The cumulative pass-rate calculation. A student with 19% per-attempt pass probability has approximately 47% cumulative probability of clearing FMGE within three attempts. Compared to top alternatives where cumulative probability reaches 65-80% across three attempts, the Chinese MBBS pathway produces materially weaker eventual licensing outcomes.

Why outcomes have weakened. Several factors contribute:

• Pandemic-era cohort disruption affecting clinical preparation
• Implementation gaps in English-medium programs at many institutions
• Curriculum misalignment with Indian medical standards (Chinese medical curriculum reflects Chinese health system priorities and traditional Chinese medicine integration)
• Limited FMGE-specific preparation infrastructure at most Chinese institutions
• Geographic and cultural distance from Indian preparation networks
• The dual-license burden requiring both Chinese qualifying examination and Indian FMGE

The structural advantages and disadvantages

China MBBS has specific structural features that Indian families should weigh:

Advantages:

• Cost: total six-year cost (₹18-35 lakh) competitive with most foreign alternatives
• Modern infrastructure at top institutions (laboratories, technology, hospital systems)
• Large affiliated hospital networks at top institutions providing case volume
• Established Indian student admission processes
• Cultural exposure to one of the world’s major economies
• Some pathway to Chinese medical practice for graduates seeking that option

Disadvantages:

• FMGE outcomes weaker than alternative destinations
• Dual-license burden (Chinese qualifying examination + FMGE)
• Mandarin language exposure required for meaningful clinical training
• Geographic distance from India and FMGE preparation networks
• Pandemic-era cohort complications continuing to affect transitional students
• Geopolitical uncertainty in India-China relations periodically affects student concerns
• Limited NMC-approved institution count (45-48) constrains admission options
• Cultural and dietary adaptation challenges substantial for many Indian students
• Variable English-medium implementation quality across institutions

When Chinese MBBS can make sense

Despite the weak average outcomes, the China MBBS pathway can produce reasonable outcomes for specific student profiles and decision contexts:

Strong student at top NMC-approved Chinese institution. Students at top Chinese medical universities (Tianjin Medical University, Capital Medical University, Wuhan University, Nanjing Medical University, Fudan University, others on the NMC list) with strong academic discipline and willingness to invest in Chinese language proficiency can produce FMGE outcomes substantially better than country average. Top-institution top-quartile outcomes can reach 30-45% per-attempt FMGE pass rates.

Students with specific China connections. Indian students with family or business connections to China that provide ongoing support, language exposure, or cultural adaptation advantages can navigate the program more effectively than students without such connections.

Students considering both Indian and Chinese practice. Indian students considering eventual practice in China (perhaps for family or business reasons) can use Chinese MBBS as the foundation for both Chinese medical license and Indian FMGE pathways. The dual-license burden becomes a feature rather than a bug.

Students with strong language aptitude. Indian students with demonstrated language learning capability who can achieve HSK-4 Chinese proficiency without compromising medical academic performance can navigate the language requirement effectively. Most Indian students find this difficult.

For most Indian families considering foreign MBBS, the combination of these favorable scenarios is narrower than the marketing suggests. Most students considering China MBBS would produce stronger expected outcomes from Bangladesh private colleges, Russia top universities, Georgia top institutions, top Nepal colleges, or Philippines top universities at comparable or moderate cost premiums.

What you must verify before enrolling

For Indian families considering Chinese MBBS, specific verifications are essential:

Verify NMC approval for the specific institution. The institution must be on the NMC-approved list (currently approximately 45-48 institutions). Verification through the current NMC website is non-negotiable. Lists change over time and old lists may not reflect current approval status.

Verify FMGL 2021 compliance. The institution’s program must satisfy 54 months single-institution coursework + 12 months same-institution internship + English-medium throughout. The English-medium requirement must apply to all clinical components, not just the basic-science years.

Verify NEET-UG status. Chinese MBBS without NEET qualification disqualifies the student from FMGE eligibility. NEET qualification documentation must be retained throughout.

Verify the Chinese medical license requirement understanding. Confirm that the student understands and is committed to passing the Chinese qualifying examination as the gateway to FMGE eligibility. The examination requires Chinese language proficiency and clinical knowledge demonstration.

Verify the institution’s recent FMGE track record. NBEMS publishes country and institution-level FMGE data. Reviewing the specific institution’s recent 3-year FMGE outcomes provides realistic indication of expected outcomes. Institutions with recent FMGE pass rates below 10% should be treated cautiously.

Verify English-medium implementation in clinical years. Confirm specifically that clinical training will be conducted in English with appropriate translation or English-speaking clinical staff support. Programs where clinical training is essentially in Mandarin with limited English support do not satisfy the language requirement effectively.

Verify the institution’s pandemic-era continuity. For institutions that experienced extensive pandemic disruption, verify that the current cohort’s program will provide continuous on-campus instruction and clinical exposure rather than continuing online or hybrid arrangements.

DreamApply note

For Indian families evaluating Chinese MBBS pathways with realistic awareness of post-pandemic structural changes, DreamUnivs offers DreamApply with structured institutional evaluation incorporating NMC approval verification, recent FMGE outcomes by specific institution, and honest comparison with alternative foreign destinations. We don’t promise admission outcomes outcomes depend on individual choices and institutional dynamics but we provide honest evaluation of when Chinese MBBS makes sense for the specific applicant and when alternatives produce better expected outcomes given the post-pandemic landscape.

The honest summary

Chinese MBBS for Indian students remains a structurally available pathway in 2026 with substantial residual Indian student volumes, but the post-pandemic landscape has weakened the realistic value proposition. FMGE country-level pass rates of approximately 19% are materially below stronger alternatives. The Chinese medical license requirement adds dual-licensing burden that no other major foreign destination imposes. Pandemic-era cohort disruptions continue to affect transitional students with complex NMC eligibility determinations. The cost advantages are real but increasingly matched or exceeded by alternative destinations with better outcomes.

The single most preventable failure mode is enrolling at NMC-approved-but-lower-tier Chinese institutions based on marketing materials that minimize the dual-license burden and post-pandemic outcome weaknesses. The single most underutilised strategic option is moderate cost premiums to top alternatives Bangladesh private, top Russia, top Georgia, top Nepal, top Philippines which produce better licensing outcomes without the dual-license burden and language barriers specific to the China pathway.

For broader context, see the foreign MBBS decision framework, MBBS abroad investigation, is foreign MBBS valid in India, and MBBS abroad countries comparison. For regulatory framework, see the FMGL 2021 explained piece, the NMC Eligibility Certificate piece, the NExT exam piece, the CRMI internship piece, and NEET-PG for foreign medical graduates. For destination comparisons, see cheapest MBBS country abroad, MBBS Russia cost, FMGE pass rate Russia, MBBS Georgia vs Kazakhstan, MBBS Philippines, MBBS Bangladesh, MBBS Nepal, MBBS Kyrgyzstan and Uzbekistan, and MBBS Ukraine status. For agent verification, see how to verify a study-abroad agent and MBBS without agent.

---

A FreedomPress publication. Send corrections, China MBBS application or institution experience, or specific scenario questions to editorial@dreamunivs.in.

Last updated: May 2026.